Publisher Correction: Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion

Affiliations

• ¹ Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.
• ² Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Tuebingen, Germany.
• ³ Department of Internal Medicine II, Hematology and Oncology, Eberhard-Karls University, Tuebingen, Germany.
• ⁴ DFG Cluster of Excellence 2180 'Image-guided and Functional Instructed Tumor Therapy' (IFIT), Eberhard-Karls University, Tuebingen, Germany.
• ⁵ Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
• ⁶ Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
• ⁷ Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
• ⁸ Division of Clinical Hematology, University Hospital Basel, Basel, Switzerland.
• ⁹ University Children's Hospital Basel, Basel, Switzerland.
• ¹⁰ Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany.
• ¹¹ Center for Biological Signaling Studies (BIOSS), University of Freiburg, Freiburg, Germany.
• ¹² Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, USA.
• ¹³ Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Medical Center, Duarte, CA, USA.
• ¹⁴ Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA, USA.
• ¹⁵ Beckman Research Institute, Duarte, CA, USA.
• ¹⁶ Institute for Pathology & Medical Genetics, University Hospital Basel, Basel, Switzerland.
• ¹⁷ Diagnostic Hematology, Department of Laboratory Medicine, University Hospital Basel, Basel, Switzerland.
• ¹⁸ Institute for Pathology, University of Tuebingen, Tuebingen, Germany.
• ¹⁹ Institute for Molecular Medicine, Goethe University, Frankfurt am Main, Germany.
• ²⁰ German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
• ²¹ Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland. claudia.lengerke@unibas.ch.
• ²² Division of Clinical Hematology, University Hospital Basel, Basel, Switzerland. claudia.lengerke@unibas.ch.